- Citations, last 5 years
- 13.8k
- Works, last 5 years
- 2 014
- h-index
- 580
- Scientists listed
- 0
- Grants since 2016
- 630
Grants received
2023–2028 · research · R01
The genetics of tumor suppression by p53
Maureen E. Murphy · The Wistar Institute · funded by National Institutes of Health
2023–2028 · research · R01
EBNA1 Inhibitor for Treatment of EBV-positive DLBCL
Paul M. Lieberman · The Wistar Institute · funded by National Institutes of Health
2023–2028 · research · R01
Metabolic and molecular regulation of myeloid cell functions in brain cancer
Filippo Veglia · The Wistar Institute · funded by National Institutes of Health
2023–2028 · research · R01
The genetics of tumor suppression by p53
Maureen E. Murphy · The Wistar Institute · funded by National Institutes of Health
2023–2028 · research · R01
EBNA1 Inhibitor for Treatment of EBV-positive DLBCL
Paul M. Lieberman · The Wistar Institute · funded by National Institutes of Health
2023–2028 · program · P01
Targeting the Epigenetic and Metabolic Control of EBV-Epithelial Cancers
Paul M. Lieberman · The Wistar Institute · funded by National Institutes of Health
2023–2028 · program · P01
Administrative and Biostatistics
Paul M. Lieberman · The Wistar Institute · funded by National Institutes of Health
2023–2028 · program · P01
Chemical Probes and Drug Discovery
Joseph M Salvino · The Wistar Institute · funded by National Institutes of Health
2023–2028 · program · P01
Models of EBV Cancer
Samantha Standish Soldan · The Wistar Institute · funded by National Institutes of Health
2023–2028 · program · P01
Epigenomic Drivers of EBV Epithelial Cancers
Paul M. Lieberman · The Wistar Institute · funded by National Institutes of Health
2023–2028 · program · P01
Methionine and PI3K Metabolism Drive CIMP in EBV Epithelial Cancers
Benjamin Elison Gewurz · The Wistar Institute · funded by National Institutes of Health
2023–2028 · program · P01
PARP1-Chromatin and NAD-Metabolism in EBV Epithelial Cancers
Italo Tempera · The Wistar Institute · funded by National Institutes of Health
2023–2028 · program · P01
EBV Genomics and Bioinformatics
Italo Tempera · The Wistar Institute · funded by National Institutes of Health
2022–2027 · research · R01
Targeting S6K2 to Overcome Drug Resistance in NRAS-mutant Melanoma
Jessie Villanueva · The Wistar Institute · funded by National Institutes of Health
2022–2024 · research · R21
Engineering HIV-resistant CAR T cells for a functional HIV cure
Daniel Thomas Claiborne · The Wistar Institute · funded by National Institutes of Health
2022–2025 · grant · DP2
Manipulating Epitope Immunodominance and Tracking B-cell-Antigen Interactions for Vaccine Design.
Amelia Escolano · The Wistar Institute · funded by National Institutes of Health
2022–2027 · research · R01
CTCF-dependent mechanisms of ATRX in neuronal differentiation
Kavitha Sarma · The Wistar Institute · funded by National Institutes of Health
2022–2026 · research · R01
ADNP mechanisms in R-loop regulation during differentiation
Kavitha Sarma · The Wistar Institute · funded by National Institutes of Health
2022–2026 · research · R01
ADNP mechanisms in R-loop regulation during differentiation
Kavitha Sarma · The Wistar Institute · funded by National Institutes of Health
2022–2023 · research · R24
Purchase of MVE Fusion Self-Sustaining Cryogenic Freezers
Luis J Montaner · The Wistar Institute · funded by National Institutes of Health
2022–2024 · research · R21
Single-cell Analysis of Glycomic and Proteomic Features of the HIV Reservoir
Mohamed Abdel Mohsen · The Wistar Institute · funded by National Institutes of Health
2022–2027 · cooperative agreement · U19
Synthetic DNA-launched and adjuvanted Env immunogens for HIV
David B. Weiner · The Wistar Institute · funded by National Institutes of Health
2022–2027 · research · R01
Design of the First Mdm2 Targeting PROTACs for treatment of p53 Mutant or Deficient Cancers
Christine M. Eischen · The Wistar Institute · funded by National Institutes of Health
2022–2027 · research · R01
Investigation into the activation of multiple bnAb precursors using structure-designed immunogens and Ig knock-in mice
Daniel Kulp · The Wistar Institute · funded by National Institutes of Health
2022–2023 · fellowship · F32
Epigenetic Pathways in ATRX-Mediated CTCF Regulation
Phillip Wulfridge · The Wistar Institute · funded by National Institutes of Health
2022–2027 · research · R01
Investigation into the activation of multiple bnAb precursors using structure-designed immunogens and Ig knock-in mice
Daniel Kulp · The Wistar Institute · funded by National Institutes of Health
2022–2027 · cooperative agreement · U19
Synthetic DNA-launched and adjuvanted Env immunogens for HIV
David B. Weiner · The Wistar Institute · funded by National Institutes of Health
2022–2027 · research · R01
New control of oncogene activation in T-cell leukemia
Chengyu Liang · The Wistar Institute · funded by National Institutes of Health
2022–2027 · research · R01
CTCF-dependent mechanisms of ATRX in neuronal differentiation
Kavitha Sarma · The Wistar Institute · funded by National Institutes of Health
2022 · fellowship · Pew Biomedical Scholars Program
Amelia Escolano — Pew Biomedical Scholar (2022)
Amelia Escolano · The Wistar Institute · funded by Pew Charitable Trusts
2022–2027 · research · R01
Targeting S6K2 to Overcome Drug Resistance in NRAS-mutant Melanoma
Jessie Villanueva · The Wistar Institute · funded by National Institutes of Health
2022–2025 · program · P01
Structural vaccinology guided development of a universal CoV vaccine utilizing nucleic acid delivered nanoparticles
Daniel Kulp · The Wistar Institute · funded by National Institutes of Health
2022–2027 · research · R01
New control of oncogene activation in T-cell leukemia
Chengyu Liang · The Wistar Institute · funded by National Institutes of Health
2022–2025 · research · R21
Single-cell Analysis of Glycomic and Proteomic Features of the HIV Reservoir
Mohamed Abdel Mohsen · The Wistar Institute · funded by National Institutes of Health
2022–2027 · research · R01
New control of oncogene activation in T-cell leukemia
Chengyu Liang · The Wistar Institute · funded by National Institutes of Health
2022–2023 · research · R01
Metabolic basis of ARID1A-mutated ovarian cancer
Rugang Zhang · The Wistar Institute · funded by National Institutes of Health
2022–2025 · research · R21
Developing a genomic toolkit to identify RNAs within non-canonical DNA structures
Kavitha Sarma · The Wistar Institute · funded by National Institutes of Health
2022–2024 · research · R21
Developing a genomic toolkit to identify RNAs within non-canonical DNA structures
Kavitha Sarma · The Wistar Institute · funded by National Institutes of Health
2022–2026 · research · R01
Epigenetic Regulation of Epstein-Barr Virus
Paul M. Lieberman · The Wistar Institute · funded by National Institutes of Health
2022–2026 · research · R01
Epigenetic Regulation of Epstein-Barr Virus
Paul M. Lieberman · The Wistar Institute · funded by National Institutes of Health